Central Nervous System Drugs Market Research Reports
Title | published | price | |
---|---|---|---|
Canavan Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... e Canavan Disease (Central Nervous System) pipeline landscape.
Canavan disease is a gene-linked neurological disorder in which the brain degenerates into spongy tissue riddled with microscopic fluid-filled spaces. Cause includes a mutati......" | 30-Nov-2022 | $2000 | |
Globoid Cell Leukodystrophy (Krabbe Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ) - Drugs In Development, 2022, provides an overview of the Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) pipeline landscape.
Krabbe disease also called globoid cell leukodystrophy is a degenerative disorder cause......" | 30-Nov-2022 | $2000 | |
Huntington Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... of the Huntington Disease (Central Nervous System) pipeline landscape.
Huntington's disease (HD) is an inherited disease that causes certain nerve cells in the brain to waste away. HD is a familial disease that is passed on from parent ......" | 30-Nov-2022 | $2500 | |
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... le System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Drugs In Development, 2022, provides an overview of the Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) (Central Nervous System) pipeline ......" | 30-Nov-2022 | $2000 | |
Progressive Supranuclear Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... 22, provides an overview of the Progressive Supranuclear Palsy (Central Nervous System) pipeline landscape.
Progressive supranuclear palsy, also called Steele-Richardson-Olszewski syndrome is a rare neurodegenerative disease that leads t......" | 30-Nov-2022 | $2000 | |
2022-2029 Global Drugs of Nervous System Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)By Maia Research "...... ng product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further opt......" | 19-May-2022 | $2980 | |
Inflammatory Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for Inflammatory Pain, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Ty......" | 02-May-2022 | $2500 | |
Visceral Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... e report provides comprehensive information on the therapeutics under development for Visceral Pain, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report a......" | 02-May-2022 | $2000 | |
Intracerebral Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... peline landscape.
The report provides comprehensive information on the therapeutics under development for Intracerebral Hemorrhage, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administ......" | 02-May-2022 | $2000 | |
Ischemic Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for Ischemic Stroke, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The ......" | 02-May-2022 | $2500 | |
|